Biotech Firm Galapagos Genomics NV To Raise Up To 40 Million Euro In Brussels-Amsterdam IPO
10/19/2005 5:12:43 PM
AMSTERDAM (AFX) - Galapagos NV said it plans to raise up to 40.25 mln eur in an initial public offering on the Brussels and Amsterdam stock exchanges.
Subscription for the shares, which are expected to sell for 8-10 eur each, will start on Monday and run until April 28. KBC Securities and Kempen & Co are joint lead managers and bookrunners.
The offering includes 35 mln eur in new shares plus 82,562 shares from the exercise of warrants, as well as an over-allotment option of new shares worth another 5.25 mln eur.
comments powered by